Andrea B. Maier, MD PhD FRACP

Oon Chiew Seng Professor in Medicine, National University of Singapore
Co-Founder and Director, NUS Academy for Healthy Longevity, National University of Singapore
Professor of Gerontology, Vrije Universiteit Amsterdam, The Netherlands
Chief Medical Officer, NU
Co-Founder, Chi Longevity
Founder, Maier’s Longevity

Andrea Maier is Oon Chiew Seng Professor in Medicine, NUS Academy of Healthy Longevity, National University of Singapore and Professor of Gerontology, Human Movement Sciences VU Amsterdam after serving from 2016 to early 2021 as Divisional Director at the Royal Melbourne Hospital, Australia, and as Professor of Medicine and Aged Care at the University of Melbourne, Australia. She graduated in Medicine from the University of Lübeck, Germany, was registered 2009 in The Netherlands as Specialist in Internal Medicine-Geriatrics and was appointed Full Professor of Gerontology at Vrije Universiteit Amsterdam (The Netherlands) in 2013. Andrea B. Maier is an authority in geroscience and precision geromedicine with more than 500 peer reviewed publications (H index 92, i10 index 382). She is invited member and advisor of international academic and health policy committees and funding agencies, including the World Health Organization evaluating the United Nations Decade of Healthy Ageing and Hevolution. She is the past Founding President of the Healthy Longevity Medicine Society and serves as selected Member of The Royal Holland Society of Sciences and Humanities, Fellow of the Atria Academy of Science and Medicine, and Board of the Academy for Health and Lifespan Research. In 2023, she co-founded the NUS Academy for Healthy Longevity to conduct, teach and disseminate Geroscience and Precision Geromedicine. To bring highest evidence-based Precision Geromedicine to clinical practice, she founded Chi Longevity - Asias first evidence based Precision Geromedicine clinics – in 2022 and established Maier’s Longevity in 2024 in The Netherlands.

 

Andrea B. Maier, MD PhD FRACP

新加坡国立大学Oon Chiew Seng医学教授
新加坡国立大学健康长寿学院联合创始人兼主任
荷兰阿姆斯特丹自由大学老年学教授
Chi Longevity联合创始人
Maier’s Longevity创始人

Andrea Maier现任新加坡国立大学Oon Chiew Seng医学教授、健康长寿学院联合创始人兼主任，同时担任荷兰阿姆斯特丹自由大学人类运动科学系老年学教授。她曾于2016至2021年担任澳大利亚皇家墨尔本医院分部主任，并任墨尔本大学医学与老年护理教授。她毕业于德国吕贝克大学医学专业，2009年在荷兰注册为内科—老年病学专科医生，并于 2013年被任命为阿姆斯特丹自由大学老年学全职教授。Maier教授是衰老科学（geroscience）和精准老年医学领域的权威，已发表超过500篇同行评审论文（H指数92，i10指数382）。

她是多个国际学术组织和健康政策委员会及资助机构的特邀成员与顾问，包括世界卫生组织（WHO，负责评估联合国健康老龄化十年项目）和Hevolution基金会。她曾任健康长寿医学学会创始主席，并现为荷兰皇家科学与人文学会成员、Atria科学与医学学院会员，以及健康与寿命研究学会理事会成员。

2023年，她联合创立了新加坡国立大学健康长寿学院，推动衰老科学与精准老年医学的研究、教学与传播。为推动循证精准老年医学在临床中的应用，她于2022年创立了亚洲首家循证精准老年医学诊所Chi Longevity，并于2024年在荷兰建立了 Maier’s Longevity。

Maggie Moon, MS, RD

Maggie Moon, MS, RD, is a Columbia University-educated, culinary school-trained, award-winning registered dietitian and best-selling author with clinical training from top-ranked New York Presbyterian Hospital of Columbia and Cornell Universities. She consults for government agencies, national non-profits, and global brands, and serves on multiple expert advisory boards.

The 2nd edition of her best-selling book, The MIND Diet: A Scientific Approach to Enhancing Brain Function published in December 2024. It is fully updated with new tips and tools based on the latest research and reader feedback. This is a book for anyone looking for practical nutrition solutions to enhance cognitive resilience, metabolic health, and mental well-being.

For professionals, Moon authored the Neurologic Disorders chapter in Krause and Mahan’s Food and the Nutrition Care Process textbook, the standard bearer for university nutrition programs; and the Brain Health chapter in The Culinary Medicine Textbook, a comprehensive guide for community health initiatives.

Maggie Moon, MS, RD 

Maggie Moon，营养学硕士（MS），注册营养师（RD），毕业于哥伦比亚大学，曾在专业烹饪学校受训，是一名屡获殊荣的注册营养师和畅销书作家，并在哥伦比亚大学和康奈尔大学的纽约长老会医院完成临床培训。她为政府机构、国家非营利组织和全球品牌提供咨询服务，并在多个专家顾问委员会任职。

她的畅销书《MIND饮食：增强大脑功能的科学方法》第二版于2024年12月出版。该书根据最新研究和读者反馈全面更新了新的建议和工具。这本书适合任何寻求实用营养解决方案的人阅读，以增强认知恢复能力、新陈代谢健康和心理健康。

在专业领域，Moon撰写了Krause和Mahan的《食品与营养保健流程》教科书中的“神经系统疾病”章节，该书是大学营养课程的标准教材；她还撰写了《烹饪医学教科书》中的“脑健康”章节，为社区健康项目提供综合指南。

Zhou Songyang, Professor, Ph.D. Supervisor.

1995-1998 Postdoctoral Fellow, Department of Cell Biology, Harvard Medical School; Department of Biology, Massachusetts Institute of Technology (MIT).
1998 -2008 Tenure and Chair Professor; Baylor College of Medicine, USA.
2009 -2015 Dean, School of Life Sciences, Sun Yat-sen University.
2009-present Professor of Sun Yat-sen University, Director of Guangzhou Key Laboratory of Healthy Aging.

Research Interests: Stem cell growth and differentiation, tumor growth and human aging mechanisms
Structure of cellular telomeres, function and mechanism of action of telomere proteins               
DNA damage and repair, protein-to-protein interactions, and signaling networks     
High-throughput screening and identification of functional genes, gene editing

So far, he has published more than 200 papers in internationally renowned journals such as Nature, Science, Cell, PNAS, Nature Cell Biology, NSMB, Molecular Cell, etc., with a total citation of more than 25,000 times, and the H-index in 2024 is 72. He has received the Scientist Paper of the Year Award and the Cell Magazine 30 Years Best 30 Article Award, the Irvington Institute Postdoctoral Fellowship, the Ellison New Scholar, the American Cancer Society Scholar and the Leukemia and Lymphoma Society Scholar.

松阳洲，教授，博士生导师

1995年-1998年，在哈佛大学医学院细胞生物学系、麻省理工学院 (MIT)生物系从事博士后工作.
1998年 -2008年，在美国贝勒医学院历任终身教授及讲题教授
2009年-2015年，任中山大学生命科学院院长
2009年至今，中山大学教授、广州市抗衰老重点实验室主任

研究领域：干细胞生长与分化、肿瘤生长和人体衰老机制、细胞端粒的结构、端粒蛋白的功能与作用机理、DNA损伤与修复、蛋白质间相互作用和信号传导网络、功能基因的高通量筛选和鉴定、基因编辑。

迄今已在Nature, Science, Cell, PNAS, Nature Cell Biology, NSMB, Molecular Cell等国际知名杂志上发表论文200多篇，总引用次数超过25,000次，2024年H-index为72。曾荣获Scientist报年度最佳论文奖和Cell杂志30年最佳30篇文章奖，Irvington Institute Postdoctoral Fellowship, Ellison New Scholar，American Cancer Society Scholar与Leukemia and Lymphoma Society Scholar等荣誉。

Howard D. Sesso, ScD, MPH, FAHA

Dr. Howard D. Sesso is an Associate Epidemiologist at the Division of Preventive Medicine at Brigham and Women’s Hospital, Associate Professor of Medicine at Harvard Medical School, and Associate Professor of Epidemiology at the Harvard T.H. Chan School of Public Health. He designs and conducts randomized clinical trials and epidemiologic studies, focusing on dietary supplements, nutrition, and lifestyle factors to prevent cardiovascular disease (CVD), hypertension, cancer, and other aging-related outcomes.
Dr. Sesso is Associate Director of the Division of Preventive Medicine and Director of Nutrition and Supplement Research at the Osher Center for Integrative Health. Dr. Sesso has been involved in several major trials at the Division of Preventive Medicine, helping lead the Physicians’ Health Study (PHS), conducting several ancillary studies in the VITamin D and OmegA-3 TriaL, and co-leading the COcoa Supplement and Multivitamin Outcomes Study (COSMOS). He has also conducted several small-scale clinical trials testing dietary supplements and nutrition, plus initiated an Epigenetics Working Group stemming from several research grants across PHS, VITAL, and COSMOS. He has published extensively, teaches courses on clinical trials and epidemiology, and enjoys mentoring students and junior faculty.

Howard D. Sesso, ScD, MPH, FAHA

Howard D. Sesso博士是美国布列根和妇女医院预防医学部流行病学副研究员、美国哈佛医学院医学副教授、哈佛大学陈曾熙公共卫生学院（Harvard T.H. Chan School of Public Health）流行病学副教授。他设计并开展随机临床试验和流行病学研究，重点关注膳食补充剂、营养和生活方式因素在预防心血管疾病（CVD）、高血压、癌症和其他与衰老相关的健康问题中的作用。

Sesso博士是奥舍综合健康中心（Osher Center for Integrative Health）预防医学部副主任兼营养与补充剂研究主任。Sesso博士参与了预防医学部的多项重要试验，帮助领导了 “医生健康研究” （PHS），在 “维生素 D 和 OmegA-3 试验” 中开展了多项附属研究，并共同领导了 “可可补充剂和复合维生素结果研究” （COSMOS）。他还开展了多项小规模临床试验，测试膳食补充剂和营养更敢于的结果，并根据 PHS、VITAL 和 COSMOS 的几项研究基金发起了表观遗传学工作组。他发表了大量论文，教授临床试验和流行病学课程，并热衷于指导学生和青年教师。

Yichuan Xiao

Principal Investigator, Head of the Immuno-Ageing Research Group, Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences

Dr. Yichuan Xiao’s lab is mainly devoted to investigating the regulation and pathogenic mechanism of immune aging. In recent years, he has been published as corresponding author in Cell (2025), Nat Immunol (2025), Immunity (2021), Nat Aging (2024), Cell Rep Med (2024), J Exp Med (2018, 2020 2021), Mol Cell (2021), Nat Commun (2018, 2019), etc., and developed several novel small molecule lead compounds targeting immune aging. He was awarded the Young Emerging Talent Award of Shanghai Society of Biochemistry and Molecular Biology, the Outstanding Tutor Award of the Chinese Academy of Sciences, and the Leading Goose Award of the Chinese Academy of Sciences. He is a member of the Anti-Aging Branch of the Chinese Society of Gerontology and Geriatrics, etc.

肖意传
中国科学院上海营养与健康研究所研究员，免疫衰老研究组组长

肖意传博士的实验室主要致力于研究免疫衰老的调控和致病机制。近年来，他以通讯作者身份在Cell (2025), Nat Immunol (2025), Immunity (2021), Nat Aging (2024), Cell Rep Med (2024), J Exp Med (2018, 2020 2021), Mol Cell (2021), Nat Commun (2018, 2019)等期刊上发表论文，并开发了多个针对免疫衰老的新型小分子先导化合物。曾荣获上海市生物化学与分子生物学会青年新秀奖、中国科学院优秀导师奖、中国科学院领雁奖等。他是中国老年学和老年医学学会抗衰老分会委员等。

Jialin Charles Zheng, M.D.: A Visionary Leader in Academic Medicine

Jialin Charles Zheng, M.D., is an internationally acclaimed medical scientist and visionary leader whose transformative impact has elevated Tongji University School of Medicine (TUSM) into a world-class academic health sciences center. As the Dean, Distinguished Professor of Neurology and Regenerative Medicine, and Director of the Brain and Spinal Cord Clinical Research Center at TUSM, he has championed a culture of excellence and collaboration.

Distinguished Academic and Research Career

Dr. Zheng's distinguished 24-year tenure at the University of Nebraska Medical Center (UNMC) in the USA, where he served as a Professor, Associate Vice Chancellor for Academic Affairs, and Associate Dean for Graduate Studies, laid a robust foundation for his international perspective. His scholarly credentials include an M.B. from Xuzhou Medical University and a Ph.D. in Neurology from Shanghai Jiao Tong University School of Medicine, complemented by postdoctoral training at UNMC and a visiting scholarship at the State University of New York at Buffalo.

His preeminence in the field is recognized through his memberships in Academia Europaea and the European Academy of Science and Arts.

Prolific Research and Scientific Contributions

A leading expert in neuroinflammation and stem cell therapy for neurodegenerative diseases such as Alzheimer's and HIV-1 associated dementia, Dr. Zheng has led numerous NIH-funded and international research projects. His prolific scientific contributions include authorship of over 260 peer-reviewed manuscripts and book chapters, and he has been honored with prestigious awards including the UNMC Gilmore Outstanding Young Investigator Award (2005) and the UNMC Outstanding Investigator Award (2008).

Transformative Leadership at Tongji University School of Medicine

Under Dr. Zheng's leadership, TUSM has achieved unprecedented growth and recognition. His key accomplishments include:

• Strategic Expansion: Orchestrating the relocation of TUSM to a dedicated, 66-acre medical campus and integrating top-tier affiliated hospitals in Ophthalmology, Dermatology, Pulmonary, Obstetrics and Gynecology and Rehabilitation,.
• Educational Excellence: Establishing the nation's leading rehabilitation education program, a Sino-German joint medical class and securing TUSM's position on the Minister of Education's 2022 list of 18 high-quality medical institutions.
• Resource Mobilization: Securing substantial private donations exceeding 350 million Chinese Yuan to advance medical education and research.
• Innovation in Medicine: Pioneering the development of an AI medical research institute to position TUSM at the forefront of healthcare innovation.

National and International Influence

Dr. Zheng's expertise extends to significant national roles, including serving as an invited expert for the National Natural Science Foundation of China (NSFC), a member of the Ministry of Education's (MOE) Education and Instruction Committee, a Certified Expert of Clinical Medicine, co-chair and an executive committee member of international brain initiative, and a member of Alliance of Academic Health Centers International (AAHCI) and Association of American Medical Colleges (AAMC) Global Workforce Advisory Panel. A dedicated bridge-builder, he has actively fostered strategic international partnerships between Chinese institutions and leading universities in the United States and Europe, further globalizing medical education and research.